Why We’re In a ‘Golden Age’ of Life Sciences Innovation

0 Ratings
0
Episode
348 of 539
Duration
21min
Language
English
Format
Category
Economy & Business

The business of life sciences came into sharp focus after the pandemic highlighted the effectiveness of mRNA vaccines in protecting people against COVID. But what exactly is life sciences and is the recent market weakness a threat to future innovation — or an opportunity? In the latest episode of Exchanges at Goldman Sachs, Amit Sinha, head of Life Sciences Investing in Goldman Sachs Asset Management, discusses the evolution of life sciences and how investors are approaching the risks and opportunities within the biotechnology sector. Learn more about your ad choices. Visit megaphone.fm/adchoices


Listen and read

Step into an infinite world of stories

  • Read and listen as much as you want
  • Over 1 million titles
  • Exclusive titles + Storytel Originals
  • 14 days free trial, then €9.99/month
  • Easy to cancel anytime
Try for free
Details page - Device banner - 894x1036

Other podcasts you might like ...